Pressure BioSciences Inc. PBIO Archives - Page 16 of 22

TuesdayDec 18, 2018 1:30 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) PCT Platform Featured in ProCan Scientific Team’s Sample Preparation Protocol

Pressure BioSciences (OTCQB: PBIO) today announced that a Centre for the Proteome of Human Cancer ("ProCan”) scientific team has published a recommended sample preparation protocol built around PBIO's Barocycler instrument system, which is designed to improve diagnosis and treatment of cancers through optimizing the identification and use of novel biomarkers. Per the update, ProCan scientists have named the new protocol Accelerated Barocycler Lysis and Extraction ("ABLE"), which is based on PBIO's proprietary pressure cycling technology ("PCT") platform for the rapid breakup of tissue samples and release of molecules for analysis. “We are pleased that ProCan has developed an advanced sample…

ThursdayDec 13, 2018 3:29 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) New Management Hire to Drive Revenue Growth, Advance Commercialization Programs

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform solutions, recently named Dr. Bradford A. Young as its senior vice president and chief commercial officer. An article discussing the company’s recent appointment reads, “Young joins the Pressure BioSciences management team with a solid entrepreneurial background and the experience of providing executive level consulting for strategic planning, product development and commercialization to various biomedical, diagnostic and pharmaceutical companies. In his new position as senior vice president and chief commercial officer, he will play a critical role in advancing the company’s commercialization…

ThursdayDec 06, 2018 9:39 am

Pressure BioSciences Inc.’s (PBIO) New Management Hire to Play Key Role in Advancing Company’s Commercialization Programs, Revenue Growth

Bradford A. Young, Ph.D., MBA was recently appointed senior vice president and chief commercial officer A very accomplished and experienced businessman and scientist, Young has helped guide and grow both startups and large companies Young is expected to leverage his technical expertise and real-world experience to drive revenue growth via major partnerships and new commercialization programs A leader in the development and commercialization of innovative, pressure-based technologies for the worldwide life sciences industry, Pressure BioSciences Inc. (OTCQB: PBIO) recently appointed Dr. Bradford A. Young as its senior vice president and chief commercial officer. The move is designed to help drive…

WednesdayNov 28, 2018 11:27 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) CEO Featured in Interview with Christine Corrado of Proactive Investors

Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform solutions, this morning announced that President and CEO Richard T. Schumacher was recently interviewed by broadcast journalist Christine Corrado of Proactive Investors, a leading multi-media news organization, investor portal and events management business. During the interview, Schmacher discussed the two major milestones that the company recently achieved in its accelerated Ultra Shear Technology (“UST”) development program, including the completion of development of the first working prototype of the UST system and the use of this prototype to demonstrate a unique…

TuesdayNov 20, 2018 9:20 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) President and CEO Featured in Uptick Newswire’s Stock Day Podcast

Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform solutions to the worldwide life sciences industry, this morning announced the featured interview of its president and CEO Richard T. Schumacher with Stock Day’s Everett Jolly. Among other highlights, Schumacher announced that the company has accomplished yet another important milestone in the advancement of its proprietary Ultra Shear Technology (“UST”) platform and commercialization program. Following the company’s recent news regarding the development of the first working prototype of the UST system, PBIO reported that it has developed a proprietary method…

ThursdayNov 15, 2018 11:13 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Third Quarter Results, Provides Business Update

Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform solutions to the worldwide life sciences industry, late Wednesday announced its financial results for the third quarter and year-to-date periods ended September 30, 2018. Among the highlights, the company achieved a significant operating loss decrease, recorded initial revenue from its new scientific services group and pursued accelerated development of its Ultra Shear Technology platform. “We are pleased to report that with tight fiscal oversight, our operating loss continued to decrease in FY 2018… At the same time, we continued to…

WednesdayNov 14, 2018 10:44 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) to Host Teleconference to Review Q3 2018 Financial Results, Provide Business Update

Pressure BioSciences Inc. (OTCQB: PBIO) this morning announced that it will host a teleconference to discuss the company’s Q3 2018 financial results and provide a business update. Interested parties may attend the call, scheduled for November 14, 2018, at 4:30 PM ET, by dialing (877) 407-8033 (North America) or (201) 689-8033 (International) and using verbal passcode “PBI Third Quarter 2018 Financial Call & Business Update.” A replay of the call will be available for 30 days, beginning on November 15, 2018, via the company’s website or by dialing (877) 481-4010 (North America) or (919) 882-2331 (International) and entering replay ID…

FridayNov 09, 2018 1:06 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Milestone in Development of Ultra Shear Technology Platform

Pressure BioSciences (OTCQB: PBIO) today announced that significant progress has been made in its development program for its proprietary Ultra Shear Technology (“UST”) platform. Per the update, the company has completed development of the first working prototype of its UST System and initiated a program to develop a proprietary method to make water soluble oils for use in multiple markets. “We believe there are significant opportunities for UST-processed nanoemulsion products in addition to the rapidly growing CBD market. Examples include large scale premium dairy and other high volume food products, as well as cosmetics, industrial lubricants, nutraceuticals, and pharmaceuticals,” Richard…

WednesdayNov 07, 2018 11:14 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Appoints Senior VP and Chief Commercial Officer Bradford A. Young, Ph.D.

Pressure BioSciences (OTCQB: PBIO) today announced appointment of its Sr. Vice President and Chief Commercial Officer Dr. Bradford A. Young, effective Monday, November 5, 2018. In this new key position, Dr. Young’s responsibilities will include assessing multiple major opportunities in new and divergent markets, as well as optimizing strategy and commercialization priorities for the company. In addition to strategic planning, Dr. Young will build customer adoption and accelerate revenue growth through driving the execution of critical partnering and commercialization programs. Young stated in the news release, "I am excited to join Pressure BioSciences at a time when I can help…

ThursdayOct 18, 2018 11:28 am

QualityStocksNewsBreaks – Pressure BioSciences Inc.’s (PBIO) New HUB880 Explorer Enables Researchers to Reach Higher Pressure Levels

Pressure BioSciences (OTCQB: PBIO) recently unveiled the HUB880 Explorer, a high-pressure based system that will empower public health, microbiology, food science, agriculture and other research scientists to study the manner in which pressure can kill food pathogens. A recent article discussing the company reads, “Through the use of the new HUB880 Explorer, researchers will become capable of reaching higher pressure levels and working with larger sample sizes. This way, the manner in which pathogens contribute to spoilage and safety hazards will be studied more thoroughly. Because of this enhancement, the HUB880 Explorer could potentially lead to higher revenue levels in…

Site Search

Company Search

Tag: Pressure BioSciences Inc. PBIO